Abstract
To demonstrate that the test drug is effective and safe for the treatment of acute viral pharyngitis in childhood. In the period from September 2019 to January 2020, 120 patients aged 6 to 18 years were treated with the drug «Doritricin» for viral pharyngitis. According to the research results it can be concluded that «Diretrizes» provides fast and high effect in pediatric practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
